Aurinia Pharmaceuticals AUPH Earnings Call Transcripts

NASDAQ AUPH
$16.62 +0.16 (+0.97%)
At close: Nov 9, 2026 · 4:00 PM EST
4 earnings calls on file for Aurinia Pharmaceuticals, from Q1 2020 to Q3 2021. Each transcript opens in a new tab.
Latest earnings call

Aurinia Pharmaceuticals Q3 2021 Earnings Call

Nov 3, 2021 8,346 words · 36 min read
  • Dana LynchDirector, Corporate Communications
  • Peter S. GreenleafChief Executive Officer
  • Joseph M. MillerChief Financial Officer
  • Massimiliano ColaoChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Aurinia Pharmaceuticals Earnings Call Transcripts

Calls4
LatestNov 3, 2021
SinceQ1 2020

Fiscal 2021

Fiscal 2020

All 4 Aurinia Pharmaceuticals transcripts Register to get access to Aurinia Pharmaceuticals’s earnings call transcripts.